RNAC

RNAC Cash Conversion Ratio

0.51×TTM

Retrieved:

RNAC FY Cash Conversion Ratio
RNAC FY Cash Conversion Ratio2.79×-1.33×
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

RNAC cash conversion ratio history

Free cash flow divided by net income. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Cartesian Therapeutics Inc Cash Conversion Ratio — Annual fiscal periods
Period endingCash Conversion Ratio
0.6093×
0.4232×
0.2338×
-0.928×
2.3929×
-0.4946×
0.9301×
0.919×
0.8079×
0.5598×
0.9385×
1.0026×

Compare cash conversion ratio

All RNAC financial metrics · RNAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.